Heart Disease Trial, Recruiting NCT06444321 Sponsor: Vestre Viken Hospital Trust Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06444321
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old
  • People who have been admitted to hospital with heart failure that has gotten worse, with symptoms such as shortness of breath, fluid build-up (such as swelling), or signs of congestion in the lungs, along with elevated levels of a specific heart-stress marker in the blood (NT-proBNP) measured at the screening stage
  • People who have been assessed as moderately to severely frail using a standard frailty scoring tool called the Clinical Frailty Scale (a score of 5 or higher) (confirm with trial site)
  • People who have given written consent to take part, and ideally also have a close family member or relative who has given consent — though family member participation is not required for eligibility

Who may not be able to join:

  • People who, due to serious other health conditions, mental health or social difficulties, or a past history of not following medical instructions, may not be able to understand or follow the trial's requirements and check-in procedures
  • People who are not able to understand Norwegian
  • People who live permanently in a nursing home and are not expected to survive for more than 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +4791367769

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Vestre Viken Hospital Trust
Registry
ClinicalTrials.gov
Start date
6 June 2024
Est. completion
1 June 2025

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Changes in symptom control and patient satisfaction; Changes in health-related quality of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov